Idivallathy Mezhugu-Vali Azhal Keel Vayu (Rheumatoid Arthritis)-A Pilot Study
- Conditions
- Health Condition 1: M057- Rheumatoid arthritis with rheumatoid factor without organ or systems involvement
- Registration Number
- CTRI/2022/02/040480
- Lead Sponsor
- ational Institute of Siddha
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Both sexes of age between 16 to 60.
Patient who meets the standard, European League against Rheumatism EULAR 2010 classification criteria.
A score >= 6 points is required for classification as definite RA.
Patients who are willing to attend OPD and IPD
Patients who are willing to undergo laboratory investigation.
Patient who are willing to sign the informed consent stating that he/ she will consciously stick to the treatment during 48 days but can stop out of the trail of his /her own conscious discretion.
Patients who are willing to follow diet restriction
Known C/O Other Auto immune diseases.
Patients receiving immunosuppressant, corticosteroids, antipsychotics, other arthritis medications including painkillers.
Known C/O Systemic Hypertension (SHT)
Known C/O Diabetes
Pregnant women.
Lactating women.
History of trauma
Known C/O Any other arthritis
Systemic complication of rheumatoid arthritis Patient.
Characteristic deformities of hand and feet in Rheumatoid Arthritis
Known C/O any other serious systemic illness like Cancer, Cardiac disease, Renal disease, Liver disorders, Neurological disorders.
Patients who had already participated in a new drug study in the past 3 months.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Reduction of EULAR Score and Clinical Symptoms from Baseline Visit to End Visit. <br/ ><br>This Study Will Discover the Therapeutic Effectiveness of also Helps to Maximize the Quality of Life and Reduce the Burden of RA Patient. <br/ ><br>Timepoint: One Month - Screening <br/ ><br>Three Month - Enrollment <br/ ><br>One Month - Assessment <br/ ><br>
- Secondary Outcome Measures
Name Time Method To record if any adverse reactionTimepoint: four months;To Record If any Any Adverse ReactionTimepoint: Four month